Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
CVS Health Corporation | CVS | 18. oct 2024 | 54.96 | -6.93 |
CVW CLEANTECH INC. | TMD0 | 18. oct 2024 | 0.54 | -2.70 |
CY4GATE S.P.A. | 68H | 18. oct 2024 | 4.63 | +0.11 |
Cyan AG | CYR | 18. oct 2024 | 2.28 | 0.00 |
CyanConnode Holdings Plc | CUAN | 18. oct 2024 | 0.12 | +8.11 |
Cyber Security 1 | 7CS | 18. oct 2024 | 0.01 | +23.81 |
CyberAgent,Inc. | CL2 | 18. oct 2024 | 6.25 | -0.79 |
CyberArk Software Ltd. - Ordinary Shares | CYB | 18. oct 2024 | 277.70 | +3.27 |
CyberCatch Global | D0K | 18. oct 2024 | 0.11 | 0.00 |
Cyberdyne Inc | 8C4 | 18. oct 2024 | 1.09 | +0.37 |
CYBEROO S.P.A. | K97 | 18. oct 2024 | 2.38 | -3.64 |
CYBERTRUST JAPAN | 5U2 | 18. oct 2024 | 12.10 | +1.68 |
Cybin | R7E | 18. oct 2024 | 9.79 | 0.00 |
Cyfrowy Polsat SA | CP9 | 18. oct 2024 | 2.72 | -0.95 |
Cymbria Corp | CYOA | 18. oct 2024 | 48.20 | -0.41 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | 18. oct 2024 | 0.13 | -3.62 |
Cytokinetics, Incorporated | KK3A | 18. oct 2024 | 49.80 | -0.40 |
Cytomed Therapeutics | F98 | 18. oct 2024 | 1.89 | -1.05 |
CytomX Therapeutics, Inc. | 6C1 | 18. oct 2024 | 0.96 | -3.66 |
Cytosorbents Corporation | HQE1 | 18. oct 2024 | 1.01 | +1.00 |
Cyviz | 8P9 | 18. oct 2024 | 2.42 | +0.41 |
Cyxone | 4CX | 18. oct 2024 | 0.00 | 0.00 |
CZG - Ceska Zbrojovka Group SE | 6QS | 18. oct 2024 | 23.60 | +0.21 |
D Amico International Shipping | B7C0 | 18. oct 2024 | 5.57 | +0.18 |
D-Box Technologies Inc. | DB2 | 18. oct 2024 | 0.04 | 0.00 |
D-Market Electronic Services & Trading ADR | 8WZ | 18. oct 2024 | 3.16 | +58.00 |
D-Wave Quantum | RQ0 | 18. oct 2024 | 0.95 | +1.60 |
D.R. Horton, Inc. | HO2 | 18. oct 2024 | 176.24 | +0.01 |
D.Western Therapeutics Institute, Inc. | 6DW | 18. oct 2024 | 0.33 | -0.60 |
D/B/A Centerspace | WXC1 | 18. oct 2024 | 65.50 | +1.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.